WeVote
Log In

Bill

Bill

HB 1587

Drug Control Act; Schedule I; Schedule IV.

2025 Regular Session Introduced by Otto Wachsmann

Virginia law reclassifies controlled substances between Schedule I and IV categories, affecting criminal penalties and medical access starting July 1, 2025.

Acts of Assembly Chapter text (CHAP0118)
0
WeVote Research Nonpartisan
Bill Summary · HB 1587

Legislative bill overview

HB 1587 modifies Virginia's drug scheduling classifications, moving certain substances between Schedule I and Schedule IV of the state's controlled substances list. The bill was signed into law and becomes effective July 1, 2025. The specific substances affected are not detailed in the action summary provided, requiring review of the actual bill text for complete understanding.

Why is this important

Drug scheduling directly impacts criminal penalties, medical availability, and enforcement priorities. Reclassifying substances can affect sentencing guidelines, research opportunities, and treatment options. This change reflects evolving policy decisions about which drugs receive the strictest legal controls versus those with recognized medical applications.

Potential points of contention

  • Lack of public detail: The summary doesn't specify which substances are being rescheduled, making it difficult for stakeholders to assess impacts on specific communities or medical practices
  • Schedule IV implications: Movement to Schedule IV (lower restriction tier) could affect law enforcement priorities and may indicate changed views on addiction/abuse potential versus medical utility
  • Implementation timeline: The July 1, 2025 effective date requires coordination between law enforcement, courts, medical providers, and correctional systems to adjust practices

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.